Skip to content
Spin & Win — Your Symphony of Fun — Symphony's Worldwide Headlines — Unleash Your Inner Athlete!

Russian Scientist Condemns U.S. Use of His Tech for Cosmetic Surgery

A Soviet-era medical breakthrough now fuels a controversial beauty trend. The inventor calls it dangerous—and never intended for plastic surgery.

,   and  Administrator
1 min read
The image shows an old book with a drawing of a man's legs and a woman's head, both of whom have...
The image shows an old book with a drawing of a man's legs and a woman's head, both of whom have bandages wrapped around their heads. There is also some text on the paper, likely providing further information about the surgery.

Russian Scientist Condemns U.S. Use of His Tech for Cosmetic Surgery

A Russian scientist has accused the United States of misusing his medical technology for cosmetic procedures. Professor Ernst Muldashev, from Bashkortostan, developed Alloplant in the 1970s for vision treatment and corneal repair. Now, he claims American surgeons are applying it in ways he never intended—including breast and buttock augmentation. Alloplant was originally designed to repair eyes and corneas using sterilised, DNA-purified fat from cadavers. The material undergoes rigorous processing to prevent immune rejection. Over time, its applications expanded to blood vessels, skin grafts, and tissue regeneration.

Muldashev holds over 60 patents for Alloplant in Russia and 10 more across the U.S., Germany, France, Switzerland, and Italy. Despite its medical success, he insists the technology was never meant for cosmetic use. He argues that breast enlargement with Alloplant is impossible and that buttock augmentation remains unproven. In the U.S., plastic surgeons have adopted the method for rejuvenation and body contouring. Patients reportedly pay around $45,000 for procedures using cadaver fat. However, the long-term risks of such treatments are still unclear. Cosmetologist Mariyat Mukhina, a dermatologist and accredited surgeon, has raised concerns about the safety of injecting processed cadaver fat for aesthetic purposes.

The dispute highlights a clash between medical innovation and commercial application. Muldashev’s technology, though patented and refined, now faces scrutiny over its off-label use. Regulatory and safety questions remain as the practice spreads in cosmetic surgery.

Read also:

Related

Latest